Associations of 25(OH) and 1,25(OH)2 vitamin D with long term outcomes in stable renal transplant recipients

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 81-89

  Keyzer, Charlotte A ^a   Riphagen, Ineke J ^a,b   Joosten, Michel M ^a,b   Navis, Gerjan ^a   Kobold, Anna C Muller ^c   Kema, Ido P ^c   Bakker, Stephan J L ^a,b   De Borst, Martin H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH STATUS; HUMAN; KIDNEY DYSFUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; BLOOD; FACTUAL DATABASE; KIDNEY; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; DATABASES, FACTUAL; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; VITAMIN D;

EID: 84920610303     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3012     Document Type: Article

References (40)

1. Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378(9800):1419-1427.
2. Heaney RP. VitaminDin health and disease. Clin JAmSoc Nephrol. 2008;3(5):1535-1541.
3. Doorenbos CR, van den Born J, Navis G, de Borst MH. Possible renoprotection by vitamin D in chronic renal disease: Beyond mineral metabolism. Nat Rev Nephrol. 2009;5(12):691-700.
4. de Borst MH, Vervloet MG, ter Wee PM, Navis G. Cross talk between the renin-Angiotensin-Aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol. 2011;22(9):1603-1609 .
5. Vaidya A, Williams JS. The relationship between vitamin D and the renin-Angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012;61(4):450-458.
6. Pilz S, Tomaschitz A, Marz W, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011;75(5):575-584.
7. Andress DL. VitaminDin chronic kidney disease:Asystemic role for selective vitamin D receptor activation. Kidney Int. 2006;69(1):33-43.
8. Liu S, Tang W, Zhou J, Stubbs JR , Luo Q, Pi M, Quarles LD. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol. 2006;17(5):1305-1315.
9. Stavroulopoulos A, Cassidy M J, Porter CJ, Hosking DJ, Roe SD. Vitamin D status in renal transplant recipients. Am J Transplant. 2007;7(11):2546-2552.
10. Marcén R, Ponte B, Rodríguez-Mendiola N, et al. Vitamin D deficiency in kidney transplant recipients: Risk factors and effects of vitaminD3supplements. Transplant Proc. 2009;41(6):2388-2390.
11. Penny H, Frame S, Dickinson F, et al. Determinants of vitamin D status in long-term renal transplant patients. Clin Transplant. 2012; 26(6):E617-23.
12. Beique LC,Kline GA,Dalton B,Duggan K,Yilmaz S. Predicting deficiency of vitamin D in renal transplant recipients in northern climates Transplantation. 2013 95 12, 1479-1484.
13. BienaiméF, Girard D, Anglicheau D, et al. Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol. 2013; 24(5):831-841.
14. de Vries AP, Bakker SJ, van Son WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component crit eria contribute equally. Am J Transplant. 2004; 4(10):1675-1683.
15. van Ree RM, de Vries AP, Oterdoom LH, et al. Abdominal obesity and smoking are important determinants of C-reactive prote in in renal transplant recipients. Nephrol Dial Transplant. 2005;20(11): 2524-2531.
16. van Ree RM, Oterdoom LH, de Vries AP, et al. Circulating markers of endothelial dysfunction interact w ith proteinuria in predicting mortality in renal transplant recipients. Transplantation. 2008; 86(12):1713-1719.
17. van Ree RM, Gross S, Zelle DM, van der Heide JJ, et al. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients. Transplantation. 2010;89(10):1247-1254.
18. Zelle DM, Corpeleijn E, van Ree RM, et al. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. Am J Transplant. 2010;10(1):106-114.
19. Doorenbos CR, de Cuba MM, Vogt L, et al. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. J Steroid Biochem Mol Biol. 2012;128(1-2):56-61.
20. Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectromet ry without derivatization. Eur J Mass Spectrom (Chichester, Eng). 2010;16(1):81-89.
21. Heijboer AC, Levitus M, Vervloet MG, et al. Determination of fibroblast growth factor 23. Ann Clin Biochem. 2009;46(Pt 4):338-340.
22. Levey AS, Stevens LA, Schmid CH, et al.Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
23. de GoeijMC,van Diepen M, Jager KJ, Tripepi G, Zoccali C, Dekker FW. Multiple imputation: Dealing with missing data. Nephrol Dial Transplant. 2013;28(10):2415-2420.
24. Harrell F E Jr., Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
25. Obi Y, Hamano T, Ichimaru N, et al. Vitamin D deficiency predicts decline in kidney allograft function: A prospective cohort study. J Clin Endocrinol Metab. 2014;99(2):527-535.
26. Jones G. Extrarenal vitamin D activation and interactions between vitamin D2, vitamin D3, and vitamin D analogs. Annu Rev Nutr. 2013;33:23-44.
27. Autier P, Gandini S. VitaminDs upplementation and total mortality: A meta-Analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-1737.
28. Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daurés JP, Argilés. Vitamin D treatment and mortality in chronic kidney disease: A systematic review and meta-Analysis. Am J Nephrol. 2013;37(3):239-248.
29. de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. Active vitamin d treatment for reduction of residual proteinuria: A systematic review. J Am Soc Nephrol. 2013;24(11): 1863-1871.
30. Courbebaisse M, Thervet E, Souberbielle JC, et al. Effects of vitamin Dsupplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 2009;75(6):646-651.
31. Kanter Berga J, Crespo Albi ach J, Beltran Catalan S, et al. Vitamin D deficiency in a renal transplant population: Safe repletion with moderate doses of calcidiol. Transplant Proc. 2010;42(8):2917-2920.
32. Danesh J, Wheeler J G, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-1397.
33. van ReeRM,de Vri es AP, Oterdoom LH, et al. Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation. Transplantation. 2009;88(2):279-287.
34. Liu PT,Stenger S,Li H,et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science. 2006 311 5768, 1770-1773.
35. Verway M, Bouttier M, Wang TT, et al. Vitam in D induces interleukin-1beta expression: Paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog. 2013;9(6): e1003407.
36. de Boer IH, Levin G, Robinson-Cohen C, e t al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults:Acohort study. Ann Intern Med. 2012;156(9):627-634.
37. WangTJ, Penci na MJ, Booth SL, et al. VitaminDdeficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
38. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
39. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortali ty risk in CKD: A meta-Analysis of prospective studies. Am J Kidney Dis. 2011;58(3):374-382.
40. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007; 72(8):1004-1013.